Mock-up Updates Study Tags (field_study_tags) - Any - ADEQUATE Blog Call-outs CLIN-Net CoMeCT COVID-19 Data Ecraid ECRAID-Base EPI-Net EPOXI Mpox NeoDeco Partners People POS-ARI-ER POS-ARI-PC POS-cUTI POS-Disease X POS-VAP Primary Care PRUDENCE RECLAIM RECOVERY REMAP-CAP SNAP SOS Covid Training 4.06.2024 ECRAID-Base holds 2024 General Assembly in Budapest All 19 member organisations met to share their progress, successes, and challenges. 29.05.2024 Watch Module 3 of Adaptive Clinical Trial Designs series This module introduces group sequential designs and sample size re-estimation. 27.05.2024 Ecraid's annual report for 2023 now available The document offers a comprehensive overview of this pivotal year for our foundation. 8.05.2024 Ecraid's successful second ESCMID Global We connected with colleagues and partners from across Europe and shared knowledge and experience with our peers. 16.04.2024 Evelina Tacconelli to receive ESCMID Lifetime Achievement Award The prestigious award acknowledges her outstanding contributions to clinical microbiology and infectious diseases. 8.04.2024 RECOVERY trial activated in France, first patient enrolled Influenza trial expands in Europe with Angers University Hospital Center site activation Load More
4.06.2024 ECRAID-Base holds 2024 General Assembly in Budapest All 19 member organisations met to share their progress, successes, and challenges.
29.05.2024 Watch Module 3 of Adaptive Clinical Trial Designs series This module introduces group sequential designs and sample size re-estimation.
27.05.2024 Ecraid's annual report for 2023 now available The document offers a comprehensive overview of this pivotal year for our foundation.
8.05.2024 Ecraid's successful second ESCMID Global We connected with colleagues and partners from across Europe and shared knowledge and experience with our peers.
16.04.2024 Evelina Tacconelli to receive ESCMID Lifetime Achievement Award The prestigious award acknowledges her outstanding contributions to clinical microbiology and infectious diseases.
8.04.2024 RECOVERY trial activated in France, first patient enrolled Influenza trial expands in Europe with Angers University Hospital Center site activation